Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunoregulatory effects of Prevenar 13 in pediatric allergic asthma and type 1 diabetes mellitus
2014-004799-50Phase 4Active
- Sponsor
- Federico Martinon Torres
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of pneumococcal 13-valent conjugate vaccine in allergic asthma, diabetes mellitus type 1 (T1D) and pneumococcal disease (3 arms), sponsored by Federico Martinon Torres. Primary endpoint: Regulatory T cell number and function. Started Dec 2014; status: active.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
allergic asthmadiabetes mellitus type 1 (T1D)pneumococcal disease
Beyond the preview
Go deeper on 2014-004799-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004799-50.